ロード中...
Future of Cholesterol Ester Transfer Protein (CETP) inhibitors: A Pharmacological Perspective
In almost 30 years since the introduction of HMG-CoA reductase inhibitors (statins), no other class of lipid modulators has entered the market. Elevation of high-density lipoprotein-cholesterol (HDL-C) via inhibiting cholesteryl ester transfer protein (CETP) is an attractive strategy for reducing th...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3720705/ https://ncbi.nlm.nih.gov/pubmed/23658137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-013-0071-8 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|